Amarin Corp Plc (AMRN)

[johngnatt]

Not really. If you look at the context, the message is more on the line that there is shortage but we have worked to fix it.

The second question, Erez, is on the US two products. One is Kuvan 500 mg powder. I think you launched the other two forms, but this one is pending FDA approval. So what’s holding it back and when do you see this getting approved? And second is on Icospaent/Vascepa. What’s the outlook for the launch? And when do you think you can have sort of a smooth supply of API?

Amit, if you can take the first one, because I don’t recall the status of it. Bear with me. We will give you the details of it in a second. As for the second, we indeed faced a shortage of supply. I believe that we overcome it and we are going to launch within the next give or take two months.

Erez, you said, you launch it in the next couple of months, but you said something about the API supply. Would it be with a smooth supply or would it be with a limited supply?
Smooth supply.

Smooth supply.